Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sexually transmitted diseases in injection drug users.

Mettassebia B Kanno1, Jonathan Zenilman

  • 1Division of Infectious Diseases, Detroit Medical Center, Wayne State University, 3990 John R, Suite 4YC, Detroit, MI 48201, USA.

Infectious Disease Clinics of North America
|October 10, 2002
PubMed
Summary

This paper outlines a diagnostic approach for sexually transmitted diseases in injection drug users. The framework includes separate protocols for asymptomatic and symptomatic patients. Asymptomatic individuals are screened using serological and molecular tests for multiple pathogens. Symptomatic patients require additional testing for genital ulcers and warts. The approach integrates both endocervical and urine-based testing for gonococcal and chlamydial DNA detection. Vaginal specimens are evaluated for Trichomonas and clue cells. The study does not introduce new diagnostic tools but synthesizes existing evidence into a structured protocol.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opinion: How to ensure regulations don't stymie much-needed COVID-19 point-of-care testing.

Proceedings of the National Academy of Sciences of the United States of America·2021
Same author

An Urgent Call for Public Health Firefighters.

Journal of public health management and practice : JPHMP·2021
Same author

Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.

JAMA·2020
Same author

Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report.

JMIR public health and surveillance·2020
Same author

Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis.

Sexually transmitted diseases·2019
Same author

First Case Report of Human Bacteremia With Malacobacter (Arcobacter) mytili.

Open forum infectious diseases·2019

Area of Science:

  • Infectious disease diagnostics
  • Substance use and public health
  • Clinical microbiology

Background:

Current understanding of sexually transmitted disease (STD) management in injection drug users remains incomplete. Prior research has shown that injection drug users face elevated risks for multiple infections due to behavioral and physiological factors. Established knowledge includes the association between injection drug use and increased transmission of blood-borne pathogens. However, diagnostic approaches specific to this population have not been fully standardized. No prior work had resolved the optimal diagnostic sequence for asymptomatic and symptomatic injection drug users. This gap motivated the development of a diagnostic framework tailored to injection drug users. That uncertainty drove the need to integrate serological and nucleic acid-based testing. The absence of a unified diagnostic algorithm for this group remains a critical issue in clinical practice.

Purpose Of The Study:

This paper aims to clarify the diagnostic approach for sexually transmitted diseases in injection drug users. The specific problem addressed is the lack of a standardized testing protocol for this population. The motivation stems from the unique risk profile of injection drug users, who may present with atypical symptoms or coinfections. The authors propose a diagnostic framework that accounts for both asymptomatic and symptomatic cases. This approach includes serological and molecular testing methods. The goal is to improve detection rates while minimizing diagnostic delays. The study does not propose new treatments or interventions. Instead, it focuses on diagnostic best practices based on existing evidence.

Keywords:
STD diagnosisinjection drug usersclinical testing protocolsmolecular diagnostics

Frequently Asked Questions

The recommended tests include VDRL, HIV antibody, hepatitis B surface antigen, and hepatitis C antibodies. Endocervical specimens are used for gonococcal and chlamydial DNA detection via culture or PCR.

Trichomonas is detected through vaginal specimen analysis, including pH testing and the presence of clue cells.

Urine specimens allow non-invasive detection of gonococcal and chlamydial DNA through PCR amplification.

Symptomatic patients require testing for genital ulcers using dark-field microscopy and HSV DNA detection or culture.

Related Experiment Videos

Main Methods:

The diagnostic approach outlined in the study is based on a combination of serological and molecular testing. Asymptomatic patients are evaluated using a screening protocol that includes VDRL, HIV antibody, and hepatitis serology. Endocervical specimens are analyzed for gonococcal and chlamydial DNA using culture or PCR methods. Urine specimens are used for nucleic acid amplification testing in some cases. Vaginal specimens are assessed for pH, clue cells, and Trichomonas. Symptomatic patients require additional testing for genital ulcers and exophytic lesions. Diagnostic tools include dark-field microscopy and DNA amplification. The framework integrates both clinical and laboratory-based assessments.

Main Results:

The diagnostic protocol for asymptomatic injection drug users includes serological and molecular testing for multiple pathogens. Gonococcal and chlamydial DNA detection is performed using culture or PCR. Urine specimens may be used for nucleic acid amplification testing. Vaginal specimens are evaluated for pH and Trichomonas. Symptomatic patients require additional testing for genital ulcers and warts. Herpes simplex virus is detected using DNA amplification or culture. Hemophilus ducreyi is assessed using Gram's stain in some regions. The protocol includes both endourethral and urine-based testing for gonococcal and chlamydial DNA. The study does not report specific detection rates or outcomes.

Conclusions:

The authors propose a diagnostic framework for STDs in injection drug users that includes both asymptomatic and symptomatic testing protocols. This approach integrates serological and molecular methods for multiple pathogens. The framework includes gonococcal and chlamydial DNA detection using culture or PCR. Urine specimens are used in some cases for nucleic acid amplification. Vaginal specimens are assessed for Trichomonas and clue cells. Symptomatic patients require additional testing for genital ulcers and warts. The study does not suggest new diagnostic tools or interventions. Instead, it synthesizes existing evidence into a structured diagnostic approach.

Hemophilus ducreyi is assessed using Gram's stain, depending on geographic risk factors.

Endourethral specimens are used for gonococcal and chlamydial DNA amplification in symptomatic patients.